Literature DB >> 23483644

Is cardiac function impaired in premotor Parkinson's disease? A retrospective cohort study.

Jose-Alberto Palma1, Maria-Mar Carmona-Abellan, Noelia Barriobero, Cristina Trevino-Peinado, Martin Garcia-Lopez, Elena Fernandez-Jarne, Maria R Luquin.   

Abstract

The objective of this study was to assess cardiovascular response during cardiac stress testing in neurologically asymptomatic individuals who developed motor features of Parkinson's disease several years after the cardiac stress testing. This was a retrospective cohort study of patients who underwent cardiac stress testing between January 2001 and December 2010. Patients were followed until May 2012 to select those who developed Parkinson's disease. Heart rate and blood pressure both at rest and at peak exercise and heart rate variability at rest were recorded. For each patient who developed Parkinson's disease, 2 matched controls who did not develop Parkinson's disease at the end of the follow-up period were selected. Patients who were diagnosed with Parkinson's disease the same day of cardiac stress testing also were selected for comparison purposes. After excluding participants who were lost to follow-up, 2739 patients remained. From this cohort, 18 (11 men) had developed Parkinson's disease 4.27 ± 2.56 years after the cardiac stress test. Thirty-six matched controls were selected. At peak exercise, the maximum heart rate and the percentage of theoretical maximum heart rate were significantly lower in patients who developed Parkinson's disease after cardiac stress testing compared with controls. The sensitivity of a maximum heart rate ≤ 143 beats per minute to predict a diagnosis of Parkinson's disease after a mean of 4.27 years was 83%, and the specificity was 62%. The results from this exploratory study demonstrate that chronotropic insufficiency may constitute an early sign of Parkinson's disease during the premotor phase, serving as potential risk factor for its diagnosis. Further investigations are needed in larger populations. © 2013 Movement Disorder Society.
Copyright © 2013 Movement Disorder Society.

Entities:  

Mesh:

Year:  2013        PMID: 23483644     DOI: 10.1002/mds.25431

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  17 in total

1.  Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Mov Disord Clin Pract       Date:  2017-03-16

2.  Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies.

Authors:  Lucy Norcliffe-Kaufmann; Horacio Kaufmann; Jose-Alberto Palma; Cyndya A Shibao; Italo Biaggioni; Amanda C Peltier; Wolfgang Singer; Phillip A Low; David S Goldstein; Christopher H Gibbons; Roy Freeman; David Robertson
Journal:  Ann Neurol       Date:  2018-03-10       Impact factor: 10.422

3.  Autonomic and electrocardiographic findings in Parkinson's disease.

Authors:  Christopher H Gibbons; David K Simon; Meilin Huang; Barbara Tilley; Michael J Aminoff; Jacquelyn L Bainbridge; Matthew Brodsky; Roy Freeman; John Goudreau; Robert W Hamill; Sheng T Luo; Carlos Singer; Aleksandar Videnovic; Ivan Bodis-Wollner; Pei S Wong
Journal:  Auton Neurosci       Date:  2017-04-14       Impact factor: 3.145

4.  Cardiocirculatory manifestations in Parkinson's disease patients without orthostatic hypotension.

Authors:  T Pérez; B Tijero; I Gabilondo; A Luna; V Llorens; K Berganzo; M Acera; A Gonzalez; A Sanchez-Ferro; E Lezcano; J J Zarranz; J C Gómez-Esteban
Journal:  J Hum Hypertens       Date:  2015-01-29       Impact factor: 3.012

5.  Natural history of pure autonomic failure: A United States prospective cohort.

Authors:  Horacio Kaufmann; Lucy Norcliffe-Kaufmann; Jose-Alberto Palma; Italo Biaggioni; Phillip A Low; Wolfgang Singer; David S Goldstein; Amanda C Peltier; Cyndia A Shibao; Christopher H Gibbons; Roy Freeman; David Robertson
Journal:  Ann Neurol       Date:  2017-02       Impact factor: 10.422

Review 6.  Non-motor features of Parkinson disease.

Authors:  Anthony H V Schapira; K Ray Chaudhuri; Peter Jenner
Journal:  Nat Rev Neurosci       Date:  2017-06-08       Impact factor: 34.870

7.  Droxidopa in neurogenic orthostatic hypotension.

Authors:  Horacio Kaufmann; Lucy Norcliffe-Kaufmann; Jose-Alberto Palma
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-06-19

8.  Treadmill gait training improves baroreflex sensitivity in Parkinson's disease.

Authors:  Mohan Ganesan; Pramod Kumar Pal; Anupam Gupta; Talakad N Sathyaprabha
Journal:  Clin Auton Res       Date:  2014-06       Impact factor: 4.435

Review 9.  Autonomic disorders predicting Parkinson's disease.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Parkinsonism Relat Disord       Date:  2014-01       Impact factor: 4.891

Review 10.  Merging Clinical and Imaging Biomarkers to Tackle Parkinson's Disease.

Authors:  Marina Picillo; Paolo Barone; Maria Teresa Pellecchia
Journal:  Mov Disord Clin Pract       Date:  2017-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.